Communiqués Amgen Inc. Sao Paulo

Actions

AMGN34

BRAMGNBDR004

Marché Fermé - Sao Paulo Autres places de cotation 18:42:47 21/06/2024			Varia. 5j.	Varia. 1 janv.
60,36 ^BRL	+0,43%		+5,49%	+20,84%

21/06	La FDA américaine approuve le médicament de Roche pour un trouble sanguin chronique	RE
14/06	Amgen Inc. annonce que la Food and Drug Administration américaine approuve le Blincyto	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Amgen : Bringing Cardiovascular Care to the Heart of Communities	20/06	PU
Amgen : Continues to Propel BiTE® Technology Innovation	20/06	PU
Amgen : Continues to Propel BiTE® Technology Innovation	14/06	PU
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE	14/06	PR
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024	12/06	PR
Amgen : Leaders Hail Southern California’s Emergence as Biotech Innovation Hub	11/06	PU
Updates On Aflibercept Biosimilar Approvals And BPCIA Litigation	11/06	AQ
FDA Approves Amgen's BKEMV, The First Eculizumab Biosimilar	11/06	AQ
Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab	10/06	AQ
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE	06/06	AQ
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE	05/06	PR
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)	05/06	PR
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE	03/06	PR
Amgen : 2024 Annual Meeting of Stockholders Presentation	31/05	PU
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	27/05	AQ
Amgen : An Underrecognized Risk Factor for Heart Disease	23/05	PU
Improving treatment responses to solid tumours with trispecific TCEs	23/05	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	22/05	PU
Amgen : Actress and Producer Gina Torres Urges Hispanic Americans to Prioritize Cholesterol Care	21/05	PU
Amgen : At Milken Global Conference, Bradway Calls for Protecting U.S. Policy Ecosystem That Fosters Innovation	20/05	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Amgen Inc. Sao Paulo

Actions

AMGN34

BRAMGNBDR004

Communiqués

Filtres